Second TMR (transmyocardial revascularisation) device wins strong backing from FDA committee
This article was originally published in Clinica
Eclipse Surgical Technologies last week won backing from an FDA panel for its transmyocardial revascularisation (TMR) system, while receiving nothing but praise on its clinical data.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.